Clinical trial
BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients…
NCT00337701 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00337701 |
|---|---|
| Title | BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection |
| Official title | Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Trimeris Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | enfuvirtide [Fuzeon] |
| Enrollment | 326 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jun 16, 2006 |
| Last update posted | Nov 3, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: